Who
David Baxley Spetzler
President
Company insider
Files Form 4 as: President, Caris Life Sciences.
In numbers
- Trades disclosed
- 26
- Buys
- 1
- Sells
- 2
- Bought
- $9,540
- Sold
- $29.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Mar 2025
- Last trade
- 4 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250,000 at $0.00 | filing |
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $610K250,000 at $2.44 | filing |
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $3.0M119,212 at $24.76 | filing |
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —250,000 at $0.00 | filing |
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $610K250,000 at $2.44 | filing |
| 4 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $3.0M119,212 at $24.76 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $2.4M1,000,000 at $2.44 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $9.7M393,100 at $24.76 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $2.1M84,900 at $25.32 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,000,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life Sciencesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,000,000 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code M | $2.4M1,000,000 at $2.44 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $9.7M393,100 at $24.76 | filing |
| 3 Sep 2026filed 4 Sep 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Sold | $2.1M84,900 at $25.32 | filing |
| 15 May 2026filed 18 May 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $211K13,856 at $15.25 | filing |
| 15 May 2026filed 18 May 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $211K13,856 at $15.25 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —83,162 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —83,162 at $0.00 | filing |
| 7 Nov 2025filed 10 Nov 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Bought | $9,540400 at $23.85 | filing |
| 11 Aug 2025filed 13 Aug 2025 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code F | $1.9M63,509 at $29.75 | filing |
News
Caris Life Sciences (NASDAQ:CAI) Stock Price Target Raised at JPMorgan Chase & Co.CAI · themarketsdaily.com · 14 Oct 2026
0 headlines in the last 90 days name David Baxley Spetzler; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.